Delivery Order SPE2DB22D3009-SPE2DB24FBB38

Award Date 7/24/24
Potential Completion Date 7/25/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB24D2010|SPE2DB25FZSX8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. It is a firm fixed-price delivery order contract with a ceiling value of $11,209.90 and an ultimate completion date of November 25, 2024. The contract does not have a set-aside designation, indicating an open competition....
This federal contract award, with an ID of SPE2DB24D2208|SPE2DB24FHGSD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S, with a ceiling value of $9,573.53 and a completion date of May 24, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $16,190.26, is a Firm Fixed Price Delivery Order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB25FUD99, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $9,798.79, is a Firm Fixed Price Delivery Order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB25FUQ24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $26,292.50, is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. It is a Firm Fixed Price Delivery Order contract with a completion date of February 20, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, with ID SPE2DB22D3102|SPE2DB25FK9KV, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with an ultimate completion date of January 7, 2025 and a ceiling value of $3,650.21. The contract is a Delivery Order under a Firm Fixed Price pricing type. There was no set-aside used for this award. Amerisourcebergen Drug Corp is a...
This federal contract award SPE2DB22D3004|SPE2DB24FND18 was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S, with a ceiling value of $18,494.68. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 11, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award, SPE2DB22D3004|SPE2DB25FNS13, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, with a ceiling value of $8,350.28, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB0A2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a medical product, with a ceiling value of $24,922.34. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 10, 2025. The contract is not designated as a...
This federal contract award, identified as SPE2DB20D3104|SPE2DB24FV6E4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $2,122.02 and covers the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract is a Delivery Order and is priced on a Firm Fixed Price basis, with an ultimate completion date of...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FBB38
    Delivery Order

This federal contract award, with an ID of SPE2DB22D3009|SPE2DB24FBB38, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S, with a firm fixed price ceiling value of $1,668.96 and a completion date of July 25, 2024. This award is not designated with a set-aside requirement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA Troop Support Medical. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:42 AM